Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy

  • Ali Shoeibi, Nahid Olfati, Irene Litvan
  • Expert Opinion on Investigational Drugs, April 2018, Taylor & Francis
  • DOI: 10.1080/13543784.2018.1460356

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Nahid Olfati